Kenneth E Fahrenholtz

Title: The Innovations of Kenneth E. Fahrenholtz

Introduction

Kenneth E. Fahrenholtz is a notable inventor based in Bloomfield, NJ (US). He has made significant contributions to the field of immunoassays and pharmaceutical compounds. With a total of 10 patents to his name, Fahrenholtz has demonstrated a commitment to advancing scientific knowledge and technology.

Latest Patents

One of his latest patents is the "Radioimmunoassay for cannabinoids." This innovative immunoassay improves the detection of cannabinoids by utilizing a combination of reagents, including an antibody, a .sup.125 I-radiolabeled antigen, an unlabeled antigen, and an anion exchange resin for the separation of labeled and unlabeled antigens. The stability of the iodinated tetrahydrocannabinol moiety is enhanced by the addition of small quantities of antioxidants such as butylated hydroxy toluene. Another significant patent involves "1,4-Disubstituted piperazine compounds." This patent discloses compounds with specific structural formulas and outlines processes and intermediates used to produce end products that exhibit both .alpha. and selective .beta. adrenergic blocking action.

Career Highlights

Kenneth E. Fahrenholtz has had a distinguished career, primarily working with Hoffmann-La Roche Inc. His work has led to advancements in both medical diagnostics and therapeutic agents. His innovative approaches have contributed to the development of new methodologies in the field.

Collaborations

Throughout his career, Fahrenholtz has collaborated with esteemed colleagues, including Robert W. Guthrie and Richard W. Kierstead. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Kenneth E. Fahrenholtz is a prominent inventor whose work has significantly impacted the fields of immunoassays and pharmaceutical compounds. His contributions continue to influence advancements in medical technology and diagnostics.